We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

PerkinElmer Appoints Karl Hecker to Head Key R&D Center

Read time: Less than a minute

PerkinElmer, Inc. has announced appointment of Dr. Karl Hecker as Director of Research & Development for its Boston-based Center of Excellence.

He will lead all product R&D efforts for the Center, which focuses on molecular medicine solutions for the company's Life and Analytical Sciences unit.

These solutions include chemistries, reagents, instruments and software serving the needs of customers engaged in areas such as proteomics, genomics and life sciences research.

Dr. Hecker joins PerkinElmer from Invitrogen and brings over 20 years of scientific experience in chemistry and biochemistry applications.

"Karl is a talented scientist and an innovative leader, and we are delighted to have him join our R&D team," said Robert F. Friel, Vice Chairman, PerkinElmer Inc.

"We are committed to adding strong domain knowledge to support our growth in the burgeoning areas of molecular medicine and this is an important step forward."

Dr. Hecker holds a Ph.D. in biochemistry from Florida State University, a master's of science degree in chemistry from Eastern Illinois University, and master's and bachelor of science degrees in chemistry from Johann Wolfgang, Goethe University, Frankfurt Germany.